Home/Filings/4/0001127602-21-005838
4//SEC Filing

Tessmer James F 4

Accession 0001127602-21-005838

CIK 0001062822other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:16 PM ET

Size

7.6 KB

Accession

0001127602-21-005838

Insider Transaction Report

Form 4
Period: 2021-02-11
Tessmer James F
VP, Finance & Acctg
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-11+24,34024,340 total
    Exercise: $8.38Exp: 2031-02-11Common Stock (24,340 underlying)
  • Award

    Restricted Stock Units

    2021-02-11+16,23016,230 total
    Common Stock (16,230 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
  • [F3]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

Entity typeother

Related Parties

1
  • filerCIK 0001434095

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:16 PM ET
Size
7.6 KB